Cargando…
Profile and potential of ixabepilone in the treatment of pancreatic cancer
The management of metastatic pancreatic adenocarcinoma is a challenge for medical oncologists because of both the aggressive nature of the disease and the relative paucity of effective systemic treatments with activity against this type of tumor. In the effort to discover new agents and combinations...
Autores principales: | Smaglo, Brandon G, Pishvaian, Michael J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106923/ https://www.ncbi.nlm.nih.gov/pubmed/25075175 http://dx.doi.org/10.2147/DDDT.S52964 |
Ejemplares similares
-
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer
por: Smaglo, Brandon G.
Publicado: (2023) -
Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
por: Rak Tkaczuk, Katherine H.
Publicado: (2011) -
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012) -
Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer
por: Egerton, Nancy
Publicado: (2010) -
Management of advanced breast cancer with the epothilone B analog, ixabepilone
por: Gradishar, William
Publicado: (2009)